This Verint Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday – Clearside Biomedical (NASDAQ:CLSD), American Healthcare REIT (NYSE:AHR)

Jul 18, 2025
this-verint-analyst-begins-coverage-on-a-bullish-note;-here-are-top-5-initiations-for-friday-–-clearside-biomedical-(nasdaq:clsd),-american-healthcare-reit-(nyse:ahr)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Baird analyst Wesley Golladay initiated coverage on American Healthcare REIT, Inc. AHR with an Outperform rating and announced a price target of $41. American Healthcare shares closed at $37.26 on Thursday. See how other analysts view this stock.
  • Evercore ISI Group analyst Amit Daryanani initiated coverage on Ralliant Corporation RAL with an In-Line rating and announced a price target of $52. Ralliant shares closed at $48.02 on Thursday. See how other analysts view this stock.
  • Wedbush analyst Alicia Reese initiated coverage on The Marcus Corporation MCS with an Outperform rating and announced a price target of $24. Marcus shares closed at $17.24 on Thursday. See how other analysts view this stock.
  • Jefferies analyst Andrew Tsai initiated coverage on Stoke Therapeutics, Inc. STOK with a Buy rating and announced a price target of $30. Stoke Therapeutics shares closed at $12.35 on Thursday. See how other analysts view this stock.
  • Rosenblatt analyst Catharine Trebnick initiated coverage on Verint Systems Inc. VRNT with a Buy rating and announced a price target of $40. Verint shares closed at $20.56 on Thursday. See how other analysts view this stock.

Considering buying MCS stock? Here’s what analysts think:

Trending Investment Opportunities

Read This Next:

Photo via Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.


Leave a comment